North America Single Cell Multiomics Market to Reach $6.15 Billion by 2031 at a CAGR of 17.6% – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “North America Single Cell Multiomics Market 2021-2031 by Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering.

The North America single cell multiomics market is projected to grow by 17.6% annually in the forecast period and reach $ 6,153.0 million by 2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication.

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Five Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America single cell multiomics market in every aspect of the classification from perspectives of Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country.

Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Instruments
• Consumables
• Software

Based on Omics Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Single Cell Genomics (SCG)
• Single Cell Transcriptomics (SCT)
• Single Cell Proteomics (SCP)
• Single Cell Metabolomics (SCM)

By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Clinical Research
• Oncology
• Cell Therapy
• Immunology
• Neurology
• Cell Biology
• Other Types of Clinical Research
• Translation Research
• Synthetic Biology

By Sample Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Human Samples
• Cancer Tissues
• Stem Cells
• Immune Cells
• Brain Cells
• Other Human Samples
• Animal Samples
• Microbial Samples

By Workflow, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Single-Cell Isolation and Dispensing
• Fluorescence-Activated Cell Sorting (FACS)
• Microfluidics
• Magnetic-Activated Cell Sorting (MACS)
• Random Seeding
• Manual Cell Picking
• Laser Capture Microdissection
• Other Technologies of Single-Cell Isolation and Dispensing
• Single-Cell Analysis
• Polymerase Chain Reaction
• Next-Generation Sequencing
• Mass Cytometry
• Mass Spectrometry
• Other Technologies of Single-Cell Analysis

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Research and Academic Laboratories
• Biopharmaceutical and Biotech Companies
• Contract Research Organizations (CROs)
• Other End Users

Geographically, the following national/local markets are fully investigated:

• U.S.
• Canada
• Mexico

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Omics Type, Workflow and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

• 10x Genomics, Inc.
• 1CellBio, Inc.
• Becton, Dickinson and Company
• Berkeley Lights, Inc.
• BGI Genomics Co., Ltd.
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• BioTuring, Inc.
• Danaher Corporation (Cytiva Life Sciences)
• Dolomite Bio
• Fluidigm Corporation
• Fluxion Biosciences
• Illimina, Inc
• Mission Bio, Inc.
• Namocell, Inc.
• NanoString Technologies, Inc.
• Parse Biosciences, Inc.
• Proteona
• Qiagen N.V.
• RareCyte, Inc.
• Scipio Biosciences SAS
• Shilps Sciences
• Takara Bio Inc. (Takara Holdings)
• Thermo Fisher Scientific Inc.

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

3 Segmentation of North America Market by Product Type

4 Segmentation of North America Market by Omics Type

5 Segmentation of North America Market by Application

6 Segmentation of North America Market by Sample Type

7 Segmentation of North America Market by Workflow

8 Segmentation of North America Market by End User

9 North America Market 2021-2031 by Country

10 Competitive Landscape

Companies Mentioned

• 10x Genomics, Inc.
• 1CellBio, Inc.
• Becton, Dickinson and Company
• Berkeley Lights, Inc.
• BGI Genomics Co., Ltd.
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• BioTuring, Inc.
• Danaher Corporation (Cytiva Life Sciences)
• Dolomite Bio
• Fluidigm Corporation
• Fluxion Biosciences
• Illimina, Inc
• Mission Bio, Inc.
• Namocell, Inc.
• NanoString Technologies, Inc.
• Parse Biosciences, Inc.
• Proteona
• Qiagen N.V.
• RareCyte, Inc.
• Scipio Biosciences SAS
• Shilps Sciences
• Takara Bio Inc. (Takara Holdings)
• Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/jhcktj

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900